1. CORPORATE NEWS LETTER
20th January 2014
SWASTIKA INTELLIGENCE GROUP
MARKET COMMENTARY
The market may edge lower in early trade tracking
mostly lower Asian stocks. Trading of CNX Nifty futures
on the Singapore stock exchange indicates that the
Nifty could fall 10.50 points at the opening bell.
The Ministry of Petroleum and Natural Gas notified the
Domestic Natural Gas Pricing Guidelines, 2014 for all
domestically produced gas, including conventional,
shale, coal bed methane (CBM). These guidelines will
be applicable from 1 April 2014.
The Reserve Bank of India said on Friday, 17 January
2014 that the liquidity conditions are undergoing some
stress in the recent period, primarily on account of the
build-up of cash balances of the Government of India.
In order to address the temporary liquidity deficit
situation, the Reserve Bank of India has been infusing
additional liquidity through 7/14/28 days term repo
auctions in addition to the existing overnight repo
under liquidity adjustment facility and standing
liquidity facilities.
Accordingly, the Reserve Bank has decided to conduct
Open Market Operations by purchasing the following
government securities for an aggregate amount of Rs
10000 crore on Wednesday, 22 January 2014 through
multi-security auction using the multiple price method.
Foreign institutional investors (FIIs) bought shares
worth a net Rs 75.27 crore on Friday, 17 January 2014,
as per provisional data from the stock exchanges.
TURNOVER IN CASH (Rs. In Crore)
NSE
BSE
12466.30
Visit us at: www.swastika.co.in
3133.56
INDIAN MARKETS As On Friday, 17th January, 2014
Particulars
BSE SENSEX
Nifty 50
Current Value
21063.62
6261.65
Points
-201.56
-57.25
% Change
-0.95
-0.91
High
21270.11
6237.10
Low
21015.61
6246.35
Previous Close
21285.18
6318.90
WORLD INDICES
US & European Markets As On, Friday, 17th Jan, 2014
Asian Markets As On, Monday, 20th Jan, 2014 at 9:00 A.M
Index
Change
SGX Nifty
6258.00
-8.50
Nikkei 225
15636.79
-97.67
Shanghai
1999.70
-5.25
Hang Seng
23041.05
-92.30
Dow Jones
16458.56
+41.55
Nasdaq
4197.58
-21.11
FTSE
6829.30
+13.88
CAC
4327.50
+8.23
DAX
9742.96
+25.25
FII Activity in Derivatives Segment (Rs. in Crore)
SEGMENT
Buy
Sell
Open Interest
INDEX FUTURES 1731.53
1976.72
14965.21
INDEX OPTIONS 11632.89 11732.81
39930.19
STOCK FUTURES 2877.53
2858.17
33180.93
STOCK OPTIONS 2020.71
2054.05
3241.57
Commodities
Crude Oil (Brent)
Comex Gold
Comex Silver
Units
$/bbl
$/oz.
$/oz.
Price
106..34
1256.00
20.33
Change
-0.14
+4.10
+0.02
Page 1 of 4

2. Company
Tata Motors
Sesa Sterlite
Tata Steel
Dr Reddy's Labs
Infosys
Wipro
ICICI Bank
HDFC Bank
MTNL
Indian ADRs Update
Price ($)
Change
30.29
13.01
14.68
43.13
60.28
13.42
35.58
34.15
0.47
0.22
0.06
0.00
-0.23
-0.42
-0.10
-0.46
-0.66
-0.02
Change (%)
0.73
0.46
0.00
-0.53
-0.69
-0.74
-1.28
-1.90
-4.47
NEWS UPDATES
Aurobindo Pharma
-European arm to buy Actavis' commercial operations in 7 European nations
-European arm to buy 7 European operations from Actavis for € 30 million
-Actavis deal gives readymade hospital sales infrastructure
-European arm to fund Actavis’ European operations buy via accruals
-European arm to sign commercial, supply deal with Actavis
-Actavis operations' 2013 sales estimated to be around € 320 million
Karnataka High Court
-Refuses to quash criminal proceedings against Vijay Mallya, Kingfisher Airlines
-Dismisses Kingfisher Airlines, Mallya petition seeking quashing of proceedings
-I-T Department moved under Section 276 (B) for non-remittance of TDS
-Non-remittance of TDS for 3 assessment years (2009-12)
-Summons were issued to Vijay Mallya and Kingfisher Airlines
Biocon introduces world's first biosimilar Trastuzumab
-Trastuzumab is a drug used for breast cancer treatment Biocon says
-Biosimilar drug CANMAb to be used for treating breast cancer in India
-CANMAb jointly developed by company and Mylan under global partnership
-Drug will be available in India by first week of February
Indoco Remedies
-Denies getting any USFDA warning letter
-Indoco Remedies ended trade on Friday down 20 percent on US FDA warning letter reports
Oil Minister
-LPG subsidy to be increased from 9 to 12 cylinders
-Hike in LPG cap to be approved by cabinet soon
JSW Holdings says
-RBI cancels company's non-banking finance company (NBFC) certificate
-Had applied to RBI for voluntary NBFC de-registration
-Can function as core invest company without registration
Visit us at: www.swastika.co.in
Page 2 of 4

3. Mahindra and Mahindra
-To observe no production days at automotive plants for 1-3 days
-To observe no production days for 3 days at Chakan plant as well
-To observe no production days for up to 3 days at plants in January 2014
-To observe no production days for aligning production with sales
- NTPC board okays Rs 12,530 crore investment for Daripali project
-TCS plans reusable software platforms
-Reliance MediaWorks board to mull delisting today
- Reliance Communications says Reliance Globalcom appoints Bill Barney as CEO
- Dewan Housing to mull interim dividend today
-Banks to recast Rs 5,000-crore debt of Era Infra Engineering
- Sasken Communications board meets today to consider proposal for payment of special dividend
-Cabinet Committee on Economic Affairs likely to take up Hindustan Zinc residual stake sale today
RESULTS DIGEST
Reliance Industries (RIL) Q3
-Net profit at Rs 5,511 crore versus Rs 5,490 crore (QoQ)
-Net revenue at Rs 1.03 lakh crore versus Rs 1.04 lakh crore (QoQ)
-EBITDA at Rs 7,622 crore versus Rs 7,850 crore (QoQ)
-EBITDA margin at 7.4 percent versus 7.6 percent (QoQ)
Wipro Q3
-IT services revenue at Rs 10,327 crore versus Rs 10,068 crore (QoQ)
-IT services revenue at USD 1,678.4 million versus USD 1,631.1 million (QoQ)
-EBIT at Rs 2,379 crore versus Rs 2,264 crore (QoQ)
-EBIT margin at 23 percent versus 22.5 percent (QoQ)
PTC India Q3
-Net profit at Rs 90.8 crore versus Rs 21.9 crore (YoY)
-Income from operations at Rs 2,613 crore versus Rs 1,878 crore (YoY)
-Other income at Rs 15.4 crore versus Rs 1.2 crore (YoY)
-Rs 4.22 crore of excess provision written back
Tata Sponge Q3
-Net profit at Rs 24.3 crore versus Rs 20.6 crore (YoY)
-Net sales at Rs 193.2 crore versus Rs 196.2 crore (YoY)
Force Motors Q3
-Net loss at Rs 8.3 crore versus profit of Rs 8 crore (YoY)
-Total income at Rs 479.5 crore versus Rs 436.3 crore (YoY)
Unichem Labs Q3
-Net profit at Rs 32 crore versus Rs 30.3 crore (YoY)
-Total income at Rs 265 crore versus Rs 232.6 crore (YoY)
-Exceptional gain of Rs 49 crore
-Declares Rs 4/share interim dividend
Visit us at: www.swastika.co.in
Page 3 of 4

4. Designation
E-mail ID
Sonakshi Bahety
Report Prepared by
Research Associate
sonakshi.bahety@swastika.co.in
RESEARCH TEAM
Santosh Sahu
Santosh Meena
Amit Khare
Vishnu Shreekar
Saloni Gupta
SWASTIKA INTELLIGENCE GROUP
Research Head
Derivatives & Technical Analyst
Commodity Analyst
Commodity Analyst
Research Associate
research@swastika.co.in
santosh.sahu@swastika.co.in
santosh.meena@swastika.co.in
amit.khare@swastika.co.in
vishnu.shreekar@swastika.co.in
salony.gupta@swastika.co.in
Disclaimer: This document is solely for the personal information of the intended recipient and must not be exceptionally used as the basi s for any investment decision. Nothing
in this document should be construed as investment, Legal, taxation or financial advice. Swastika Investmart Ltd. is not soliciting any action based upon it. Each recipient of this
document should make necessary investigations as they consider important to arrive at an independent evaluation of an investment in the securities of the companies referred
to in this document (including the merits and risks involved). This report has been made based on information that we consider reliable and are publicly available but we do not
state that it is accurate or complete and it should not be solely relied upon such, as this document is for.
Swastika Investmart Limited, its affiliates, directors, its proprietary trading and investment businesses may, from time to time, make investment decisions that are inconsistent
with or contradictory to the recommendations expressed herein. The views contained in this document are those of the analyst, and the company may or may not subscribe to
all the views expressed within this document.
Swastika Investmart Limited or any of its affiliates/ group companies, or employees shall not be in any way held responsible for any loss or damage that may arise to any person
from any inadvertent error in the information contained in this report.
Swastika Investmart Limited has not independently verified the information contained in this document. Accordingly, we cannot testify, nor make any representation or
warranty, express or implied, to the accuracy, contents or data contained within this document. This document is being supplied to you solely for
your information, and its contents, information or data may not be reproduced, redistributed or passed on, directly or indirectly.
Visit us at: www.swastika.co.in
Page 4 of 4